The SEC Spreads The Love
Millipore’s announcement last week was unusual. The Massachusetts-based life science firm said in its 10-Q that the SEC won’t bring an enforcement action for potential Foreign Corrupt Practices Act violations the company self-reported in 2006.… Continue Reading